Actively Recruiting

Age: 18Years +
All Genders
NCT05575440

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

Led by Mayo Clinic · Updated on 2026-02-27

24

Participants Needed

1

Research Sites

314 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This phase II study evaluates F-18 tetrafluoroborate (18F-TFB) PET/CT scan in patients with differentiated thyroid cancer. Diagnostic imaging is necessary for planning treatment, monitoring therapy response, and identifying sites of recurrent or metastatic disease in differentiated thyroid cancer. 18F-TFB PET/CT may accurately detect recurrent and metastatic thyroid cancer lesions, with the potential to provide information for patient management that is better than the current standard of care imaging practices.

CONDITIONS

Official Title

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Biopsy-proven papillary or follicular thyroid cancer
  • Clinically indicated for 123I-SPECT/CT total body iodine scan
  • Agree to undergo 18F-TFB PET/CT scan after TBI scan
  • Karnofsky performance status of 50 or higher (or equivalent ECOG/WHO status)
  • Able to lie still on SPECT/CT and PET/CT scanner table for up to 65 minutes
  • Age 18 years or older
  • Able to understand and willing to sign informed consent
  • Not pregnant
Not Eligible

You will not qualify if you...

  • Contrast-enhanced CT within the last 4 weeks
  • Use of amiodarone within the last 4 months
  • Ingested iodine, kelp tablets, Lugols iodine, or potassium iodide within 2 weeks
  • Unable to lie flat, still, or tolerate a PET scan
  • Applied betadine, iodoform, or quick tanning products to skin within last 2 weeks
  • If using medication withdrawal for stimulation, thyroid stimulating hormone level less than 25
  • Taken anti-thyroid medication within 1 week
  • Breastfeeding
  • Positive pregnancy test

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here